AI-Driven
In collaboration with ![]()

Get Instant Access – Enter Your Details Now!
Artificial Intelligence (AI) is transforming the landscape of the life sciences industry, particularly in product development and patient-centric innovation. The life sciences sector is dedicated to discovering new therapies, treatments, and cures to improve human life quality.
This round table discussion will delve into the impact of AI on these areas, exploring how AI-driven approaches are revolutionizing drug discovery, clinical trials, and personalized medicine.
Join Marlabs’ experts as we explore the importance of benefits of AI:
- Accelerating drug discovery and development processes.
- Enhancing precision medicine through patient stratification techniques.
- Utilizing data-driven insights to customize treatments for individuals.
- Employing predictive analytics to optimize clinical trials.
Key Takeaways:
- AI in Drug Discovery: Discover how AI is streamlining the drug discovery process, from target identification to lead optimization, reducing time and costs.
- AI in Clinical Trials: Learn about the role of AI in optimizing clinical trial design, patient recruitment, and data analysis, leading to faster and more efficient trials.
- AI in Personalized Medicine: Understand how AI is enabling personalized medicine by analyzing large datasets to tailor treatments to individual patients, improving efficacy and reducing adverse effects.
Data Practitioners
Years in Business
Strategic Partnerships
Proven Frameworks & Accelerators
Meet the Panel
Arjun Ahlawat
Arjun Ahlawat, the Global Business Head of Life Sciences and Automation Advisory Unit at Marlabs. With over 20+ years of experience in consultative sales, digital consulting, and P&L management, Arjun has a proven track record of helping Fortune 500 customers improve business processes and enhance customer experiences.
Durga Ambati
Durga Ambati is a Practice Director on the Life Sciences Information Technology Services team and leads the focus on the commercial technology and medical devices industry. She advises business and IT leaders of technology vendors, service providers, and life sciences enterprises across various topics, including growth strategy, M&A support, business intelligence, go-to-market strategy, competitive intelligence, and market positioning. She has authored multiple industry reports and vendor assessments in the life sciences, commercial technology, and medical device technology domain and drives the research and thought leadership across these areas. Prior to joining Everest Group, Durga worked as a product development lead and clinical marketing specialist at a US-based medical device start-up. She holds a bachelor’s and master’s degree in biological sciences from the Indian Institute of Technology (IIT), Madras.
Purnima Menon
Purnima is Chief Marketing Officer at Marlabs. She has over 24+ years of experience in providing marketing and strategic thought leadership to large organizations. Purnima is focused on marketing Marlabs’ digital expertise and holds the responsibility for strategic marketing, analyst relations, sales enablement and corporate communications.
Rise of AI in pharma
The COVID-19 pandemic accelerated AI adoption in the pharma industry. An increasing number of pharmaceutical companies are applying AI driving new business value. Global pharma companies are finding increasingly digital and intelligent ways to boost manufacturing, research and drug discovery.
Divergent Thinking in Action: Inside a Marlabs Design Thinking Workshop
Marlabs’ Design, Advisory & Consulting practice helps enterprises rapidly identify and innovate to create new revenue opportunities and customer experiences. Watch this video to know how you can benefit from a design-led, consultative business relationship.